Open AccessResolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»
Author(s) -
M.B. Antsiferov Antsiferov,
Анциферов Михаил Борисович,
Gagik R. Galstyan,
Галстян Гагик Радикович,
Alexey Zilov,
Зилов Алексей Вадимович,
Alexander Y. Mayorov,
Майоров Александр Юрьевич,
Т. Н. Маркова,
T.V. Markova,
N.A. Demidov Demidov,
Демидов Николай Александрович,
O.M. Koteshkova Koteshkova,
Котешкова Ольга Михайловна,
Д. Н. Лаптев,
Лаптев Дмитрий Никитич,
Alisa V. Vitebskaya,
Витебская Алиса Витальевна
Publication year - 2019
Publication title -
saharnyj diabet
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 12
eISSN - 2072-0378
pISSN - 2072-0351
DOI - 10.14341/dm10227
Subject(s) - glycemic , medicine , context (archaeology) , diabetes mellitus , intensive care medicine , endocrinology , paleontology , biology
The Scientific Advisory Board, chaired by Professor G. R. Galstyan (cochair - A.V. Zilov), met in Moscow on 19 June 2018 to discuss the possibilities of improving the results of diabetes mellitus (DM) treatment by considering glycaemic variability (GV) as an additional criterion for effective glycaemic control (especially in patients receiving insulin therapy) and as one of the goals of treatment in patients with unstable glycaemia.
The purpose of the working meeting was to develop a strategy for the introduction of GV as a predictor and as an additional criterion for assessing the effectiveness and safety of hypoglycaemic therapy to improve the pharmacotherapy of diabetes and reduce cardiovascular and total mortality.
The aims of the working meeting were to conduct a comprehensive data analysis of the relationship between GV and hypoglycaemia; to gather and analyse published data and the experience of decrease in GV and improved outcomes of diabetes against the background of different types of insulin therapy; to compare existing methods of glycaemia monitoring and GV assessment and examine their validity and availability in real practice in the context of limited budget and to analyse the informativeness and clinical and prognostic significance of various parameters of GV assessment and to determine their reasonable minimum for a comprehensive assessment of GV as a criterion for evaluating the effectiveness of DM treatment and the predictors of negative diabetes outcomes.
The following reports were presented during the discussion: Glycemic variability: clinical and prognostic value. Types of glycemic variability (Candidate of Medical Sciences, assistant Professor Zilov A.V.); Methods of assessment of variability of glycemia in clinical trials and routine practice (PhD, Professor Markova T. N.); Current international and national recommendations on glycemic monitoring (PhD, Professor Galstyan G. R.) and Peculiarities of glycemic variability and its evaluation among children and adolescents (Candidate of Medical Sciences Vitebskaya A.V.).